SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 40-F - Registration statement [Section 12] or Annual Report [Section 13(a), 15(d)]:
SEC Accession No. 0001062993-08-001417
Filing Date
2008-04-01
Accepted
2008-04-01 17:14:25
Documents
16
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT FOR THE FISCAL YEAR ENDED DECEMBER 31, 2007 form40f.htm 40-F 20151
2 ANNUAL INFORMATION FORM exhibit99-1.htm EX-99.1 292665
3 AUDITED CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEARS ENDED DECEMBER 31, 2007 exhibit99-2.htm EX-99.2 369767
4 MANAGEMENT???S DISCUSSION AND ANALYSIS FOR THE YEAR ENDED DECEMBER 31, 2007 exhibit99-3.htm EX-99.3 99371
5 CERTIFICATION exhibit99-4.htm EX-99.4 7378
6 CERTIFICATION exhibit99-5.htm EX-99.5 7405
7 CERTIFICATION exhibit99-6.htm EX-99.6 2745
8 CERTIFICATION exhibit99-7.htm EX-99.7 2782
9 CONSENT exhibit99-8.htm EX-99.8 1905
10 logo.gif GRAPHIC 2126
11 exhibit99-1x14x1.jpg GRAPHIC 14394
12 exhibit99-2x1x1.jpg GRAPHIC 2222
13 exhibit99-2x1x2.jpg GRAPHIC 2391
14 exhibit99-2x7x1.jpg GRAPHIC 1832
15 exhibit99-2x7x2.jpg GRAPHIC 1436
16 eysig.jpg GRAPHIC 2618
  Complete submission text file 0001062993-08-001417.txt   843670
Mailing Address 8900 GLENLYON PARKWAY SUITE 100 BURNABY A1 V5J 5J8
Business Address 8900 GLENLYON PARKWAY SUITE 100 BURNABY A1 V5J 5J8 6046814101
RESPONSE BIOMEDICAL CORP (Filer) CIK: 0000806888 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 40-F | Act: 34 | File No.: 000-50571 | Film No.: 08730319
SIC: 8734 Services-Testing Laboratories
Assistant Director 9